Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Was Jim Cramer Right About These 12 Stocks?

In this article, we will take a look at 12 stocks that Jim Cramer discussed 6 months ago during his show on July 29, 2024, and examine whether he was right or wrong about those stocks.

Back then, Cramer was talking about the “great broadening” which he described as the event where every stock was rallying except for the large cap stocks. He said:

“This market is not experiencing a small cap rally, it’s experiencing a rally in everything else but the tech titans.”

He also pointed out that many small-cap stocks were being bought indiscriminately through index funds like the Russell 2000, the S&P Small Cap 600, and the S&P Mid Cap 400.

“The big institutions don’t have time to examine all these different small-cap stocks, they just buy the index itself as an entity because it’s still historically cheap, even after this rally.”

That’s the essence of the broadening—some real treasures and some real trash getting scooped up together. He then explained:

“The treasure being companies that do better when interest rates go down like when the Fed starts cutting.”

Unlike the cash-rich tech giants that don’t need lower interest rates, small caps benefit tremendously from falling rates. That’s why investors were selling their big-tech winners from earlier in the year and cycling into cheaper small-cap stocks.

Jim Cramer was particularly enthusiastic about this narrative back then and said that investors should “celebrate the market’s good breadth”.

Our Methodology

For this article, we compiled a list of 12 stocks that were discussed by Jim Cramer during the episode of Mad Money on July 29, 2024. We then calculated their performance from July 29th, 2024, market close to February 4th, 2025, market close. We have also included the hedge fund sentiment for the stocks, which we sourced from Insider Monkey’s Q3 2024 database of over 900 hedge funds. The stocks are listed in the order that Cramer mentioned them.

Note: This article covers Jim Cramer’s commentary from July 29, 2024, and does not account for any changes in his opinions regarding the stocks mentioned. Therefore, the commentary should not be mistaken for his latest opinions on any of the stocks that are mentioned.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

12. McDonalds (NYSE:MCD)

Number of Hedge Fund Investors: 60

McDonald’s had reported weak same-store sales back then, missing both revenue and earnings expectations. But instead of getting punished, the stock jumped nearly 4%. But Cramer wasn’t buying the optimism, saying:

“Frankly, nobody was truly disappointed by McDonald’s because everyone expected them to have bad numbers.”

The company had rolled out a $5 value meal plan to spark demand, but Cramer saw it as a desperation move:

“The fact that McDonald’s would kick out a plan to return to growth was enough to get everyone excited.”

However, the stock is up 11% since the episode aired in July, which shows that McDonald’s growth has, in fact, been working so far.

11. 3M Company (NYSE:MMM)

Number of Hedge Fund Investors: 82

Cramer seemed enthusiastic about the stock, suggesting that a change is happening at 3M Company. With a new CEO, Bill Brown, in charge, the company was aggressively cutting costs and identifying new growth areas. That was enough to send the stock soaring 23% at the time. Cramer said:

“All it took for the stock to rally was the CEO talking about where he sees cost cuts and multiple segments that could grow faster.”

This wasn’t about takeover speculation—it was about 3M Company playing catch-up after years of struggles. Cramer liked that Brown was taking an active approach to fixing the company, and he saw momentum building behind the turnaround.

Jim’s optimism was spot on, as the stock has rallied by an additional 20% since the end of July.

10. Bristol Myers (NYSE:BMY)

Number of Hedge Fund Investors: 72

Bristol Myers had been left for dead on Wall Street, plagued by years of missed earnings and patent concerns. But at the time the show aired, the company surprised everyone by raising its full-year guidance and delivering a huge earnings beat. Cramer emphasized:

“What happened with Bristol-Meyers is that after years of repeatedly missing earnings estimates, a new CEO came in and now they’re knocking it out of the park”.

He saw the market finally rewarding a well-executed turnaround, saying:

“They can’t just rely endlessly on Eli Lilly,” he warned, highlighting how Bristol needed a fresh drug pipeline to win back investor confidence.

With new leadership in place and strong execution, Cramer liked the stock again.

And he’s been right about that, with the stock being up more than 20% since his comments.

9. Meta Platforms Inc. (NASDAQ:META)

Number of Hedge Fund Investors: 239

A caller asked about Meta’s outlook over the next 1-2 years, and Cramer acknowledged that the stock is facing selling pressure despite its strong fundamentals, saying:

“The problem with Meta right now is it’s gone up so much that people are just selling Meta to buy a lot of stuff in the small and medium-sized range.”

Cramer thinks this trend isn’t going to change anytime soon, regardless of what Mark Zuckerberg says.

“Just be aware that the stock’s in the doghouse right now, and it could come out of it only if it gets even cheaper.”

However, the stock hasn’t gotten any cheaper since then. In fact, it has risen by more than 50% since Cramer’s comments.

In fairness, Jim Cramer has also changed his stance on the stock since then, having praised the company and its CEO Mark Zuckerberg in a more recent episode, saying:

“The second wild card, Meta Platforms. I think the company will talk about dominance, visceral, raw dominance, both on the top and the bottom line. Lookout, TikTok, you think you’re so darn hot, but Mark the Hunter Zuckerberg has you in his sights. I for one am glad that Zuckerberg’s an American.”

8. On Semiconductor (NASDAQ:ON)

Number of Hedge Fund Investors: 45

ON Semiconductor had a history of disappointing earnings, and expectations were low. But this time, the company beat estimates, delivering a solid quarter and an 11% stock rally. Cramer mentioned in his old episode about how the trend was changing:

“ON Semiconductor reported and we’ve gotten used to it missing the numbers. It’s kind of like a old shoe missing numbers at this point but not this time.”

He then quoted the company’s CEO Hassane El-Khoury who pointed to stabilizing demand in core markets, adding that China was recovering in both industrial and auto.

Cramer’s verdict? The rotation out of Nvidia (NVDA) and into the rest of the chip space was in full effect. He saw ON Semi as a major beneficiary, saying:

“You’ll see a wholesale redistribution from the once loved Nvidia to everything else.”

However, the stock has been taking a beating since then, being down by 35%. Jim has been more cautious on the semiconductor stocks recently, saying:

“The semiconductor cohort is all over the place. The ones selling into the AI team are still doing pretty well, but anything cyclical like Texas Instruments or ON Semi has, it had a real tough go.”

7. Lamb Weston Holdings (NYSE:LW)

Number of Hedge Fund Investors: 39

Lamb Weston had suffered a brutal 28% collapse, its second major earnings disaster in a row. The company, which supplies frozen potato products, had become one of the worst-performing stocks in the S&P 500. Cramer wasn’t surprised at the time and said:

“Lamb Weston was a total home run for a long time, but suddenly, it’s one of the worst stocks in the market.”

He then highlighted the company’s problems, such as reduced restaurant traffic, the potato glut that has been killing its margins and that GLP-1 weight loss drugs were big threats to the stock. But he also saw an opportunity in the weakness, saying:

“At some point, The Great Potato Glut will end. This stock has been cut in half—it’s now dirt cheap.”

Even if Lamb Weston disappoints further, the downside may be limited. Cramer wasn’t calling a bottom at the time, but for investors with patience, he saw a chance to pick up shares slowly before a long-term recovery.

It appears that Cramer was spot on with this one. Although the stock hasn’t performed exceptionally, being up by just 6% since, the stock did hit its bottom a few days before the program aired on July 29th.

6. Columbia Sportswear (NASDAQ:COLM)

Number of Hedge Fund Investors: 15

Columbia had been dealing with weak retail sentiment, but international growth and product innovation were keeping the brand strong. Cramer was particularly impressed by Columbia’s new “polar bear” technology, designed to retain heat in extreme cold. He praised it by saying:

“This is a real game-changer, and I think it’s going to be a major hit.”

Columbia was also working through excess inventory and improving its direct-to-consumer strategy.

In general, Jim Cramer repeatedly praised the CEO and emphasized how much he likes the company and its focus on innovation:

“I got to tell you, I love your stuff; everybody does because there’s always some new technology … I think it’s the technology that is crucial to the company and you always deliver.”

The stock has been doing well since then, being up by 10%.

5. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Investors: 64

Abbott had lost a massive $495 million lawsuit over specialized baby formula back when the episode was aired, and Cramer said at the time:

“I knew Abbott Labs was in trouble, but I didn’t know the extent of the damage … honestly, this verdict is an outrage.”

Abbott’s formula is used in neonatal intensive care units and recommended by doctors—yet trial lawyers successfully convinced a jury that it was causing harm, despite no clear scientific evidence.

His fears were that Abbott might pull the product entirely rather than risk further lawsuits—just like Johnson & Johnson did with baby powder. Abbott initially dropped but rebounded by the close, which Cramer saw as a sign that Wall Street saw the lawsuit as excessive:

“I’m honestly amazed that Abbott’s stock after open is down more than 4% … perhaps that’s because the stock’s already down, perhaps it’s because Wall Street recognizes a joke when it sees one.”

He expressed his stance against the lawsuit, supporting the notion that the company wasn’t actually trying to profit from this product, saying:

“The company didn’t hide anything. I very much doubt the risk, and the product’s a money loser anyway”.

The stock however, has rallied by 23% since Cramer’s comments in July 2024.

More recently in January 2025, Cramer praised the company, noting:

“Abbott, not understood very well because they’re doing tremendous stuff when it comes to diabetes. People don’t seem to care.”

4. Texas Instruments (NASDAQ:TXN)

Number of Hedge Fund Investors: 60

A caller asked Cramer whether this was a good time to restart a position in Texas Instruments and Cramer didn’t hesitate to say yes.

He suggested that TXN is in a good position for a rebound. But what really caught his attention was the presence of activist investor Elliott Partners. He explained:

“They reported good numbers, and you have an activist in there—Elliott Partners—that can make a lot of things happen. By the way, they’re in Starbucks, and I think they can make a lot of things happen there and in Southwest too.”

Cramer also spoke about the company’s strategic meeting and viewed it as a catalyst, saying:

“I think they’re going to have a very big meeting that’s going to lay out the strategy, and the stock’s going to go up well in advance of that.”

However, the stock has dropped by more than 10% since the program aired in July.

3. Morgan Stanley (NYSE:MS)

Number of Hedge Fund Investors: 56

A caller called in with a strong case for Morgan Stanley, highlighting strategic initiatives, strength in investment banking, and growth in wealth management.

Cramer wholeheartedly agreed.  He pointed out that big IPOs and takeover deals drive Morgan Stanley higher, and he expects more of both in the near future, saying:

“When we do pieces about these big IPOs and we get a lot of takeovers, you’re going to see Morgan Stanley go higher and higher and higher.”

His view is that Morgan Stanley remains a strong buy, especially if rate cuts fuel more market activity and he was spot on. The stock has soared by more than 33% since his comments.

2. Bank of America (NYSE:BAC)

Number of Hedge Fund Investors: 102

A caller wanted to know what was going on with Bank of America’s recent pullback and asked about a good entry point. Cramer saw an opportunity and advised the caller:

“You buy some right here. Buy some—maybe if it breaks 40.”

He thought Bank of America was selling too cheaply and remains one of the best-positioned banks to benefit from rate cuts and an improving economy:

“I think this company’s selling very inexpensively, and it’s a good one.”

Jim Cramer’s bullish comments on the banks were pretty accurate. Bank of America also rose by 14% since the program aired in July 2024.

1. Constellation Energy (NASDAQ:CEG)

Number of Hedge Fund Investors: 78

A caller asked whether they should buy more, hold, or sell Constellation Energy. Cramer issued a clear buy on the stock, saying:

“Look, this is a solar play that is a very good company.”

Constellation Energy is one of the largest producers of carbon-free electricity in the U.S., with a strong focus on nuclear, wind, and solar power generation. As demand for renewable energy and grid reliability grows, the company has positioned itself as a leader in the transition to cleaner power sources.

Despite the stock having already soared by that time, Cramer didn’t hide his bullish stance:

“It’s up a huge amount—47% for the year—but I think you can buy some. Please hold on to it. Do not sell it.”

Cramer gave some good advice to the caller, with the stock being up by an additional 83% since July 2024.

While we acknowledge the potential of CEG as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CEG but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure: None. This article was originally published at Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.